(Reuters) – Sage Therapeutics Inc and Biogen’s experimental drug showed improvement in depressive symptoms among women with postpartum depression at day 15, meeting the main goal of a late-stage study, the companies said on Wednesday.
(Reporting by Amruta Khandekar; Editing by Devika Syamnath)
